Global Picture Archiving and Communication System Market Report

The “Global Picture Archiving and Communication System Market 2022-2026” report has been added to ResearchAndMarkets.com‘s offering.

The picture archiving and communication system market is poised to grow by $1.34 bn during 2022-2026, accelerating at a CAGR of 5.89% during the forecast period. The report on the picture archiving and communication system market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by government initiatives encouraging IT adoption in healthcare, increasing adoption of PACS by small hospitals and imaging centers, and increasing demand for mobile PACS.

The picture archiving and communication system market analysis includes the product and application segments and geographic landscape.

The picture archiving and communication system market is segmented as below:

By Product

  • Mid-end PACS
  • Enterprise PACS
  • Mini PACS

By Application

  • Radiology PACS
  • Cardiology PACS
  • Pathology PACS

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the emergence of cloud-based PACS as one of the prime reasons driving the picture archiving and communication system market growth during the next few years. Also, increasing healthcare expenditure and increasing providers for patient-centered radiology solutions will lead to sizable demand in the market.

The report on the picture archiving and communication system market covers the following areas:

  • Picture archiving and communication system market sizing
  • Picture archiving and communication system market forecast
  • Picture archiving and communication system market industry analysis

Key Topics Covered:

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Five Forces Analysis

5 Market Segmentation by Product

6 Market Segmentation by Application

7 Customer Landscape

8 Geographic Landscape

9 Drivers, Challenges, and Trends

10 Vendor Landscape

11 Vendor Analysis

12 Appendix

Companies Mentioned

  • 314e Corp.
  • Agfa Gevaert NV
  • Apollo Enterprise Imaging Corp.
  • Ashva Technologies Pvt. Ltd.
  • Carestream Health Inc.
  • Cerner Corp.
  • Dell Inc.
  • Esaote Spa
  • FUJIFILM Holdings Corp.
  • General Electric Co
  • Intelerad Medical Systems Inc.
  • International Business Machines Corp.
  • Koninklijke Philips NV
  • Laitek Inc.
  • Lexmark International Inc.
  • McKesson Corp.
  • Novarad Corp.
  • PaxeraHealth
  • Sectra AB
  • Siemens AG

For more information about this report visit here.

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.